Archive for the ‘Breast Cancer’ Category
Friday, March 5th, 2010
A new study, led by researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies. Results were published in the Journal of Clinical Oncology...
Monday, March 1st, 2010
Hypnosis can help alleviate the pain and suffering experienced by women being treated for breast cancer, according to a study by a University at Buffalo School of Social Work professor. The randomized trial measured pain and suffering, frequency of pain and degree of constant pain among 124 women with metastatic breast cancer, according to Lisa D...
Thursday, February 18th, 2010
Breast cancer survivors who regularly took aspirin after completing treatment were 50% less likely than survivors who did not take aspirin to die or have a recurrence, according to a study published Wednesday in the Journal of Clinical Oncology, USA Today reports (Szabo, USA Today, 2/17)...
Wednesday, February 17th, 2010
Male breast cancer is a rare type of cancer that forms in the breast tissue of men. Breast cancer is often thought of as a condition that only affects women, but men can also develop the condition. Yet, male breast cancer is much less common than female breast cancer. Male breast cancer can occur at any age; however it is most common in older men...
Monday, January 25th, 2010
Environmental Cues Lead to Breast Cancer A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer...
Wednesday, January 20th, 2010
The 7th European Breast Cancer Conference (EBCC-7) will be held in Barcelona, Spain (Centre Convencions Internacional (CCIB - FORUM), Rambla Prim 1-17, ES-08019) from Wednesday 24 - Saturday 27 March 2010. The most exciting breast cancer conference in Europe, it is the only one that involves all the major players in breast cancer...
Friday, January 1st, 2010
The National Institutes of Health has awarded a three-year grant of more than $1.2 million to The Scripps Research Institute to develop a series of high-throughput screening tests that will help speed the discovery of potential small molecule therapies for breast cancer and cardiovascular disease...
Tuesday, December 15th, 2009
1. Less Invasive Core Needle Biopsy Almost as Effective as Open Surgical Biopsy for Breast Lesion Diagnosis Women suspected of having breast cancer are usually referred for a breast biopsy to determine whether the lesion is cancerous. In most cases, breast lesions are not cancers and do not require further treatment...
Tuesday, December 15th, 2009
1. Less Invasive Core Needle Biopsy Almost as Effective as Open Surgical Biopsy for Breast Lesion Diagnosis Women suspected of having breast cancer are usually referred for a breast biopsy to determine whether the lesion is cancerous. In most cases, breast lesions are not cancers and do not require further treatment...
Tuesday, December 15th, 2009
1. Less Invasive Core Needle Biopsy Almost as Effective as Open Surgical Biopsy for Breast Lesion Diagnosis Women suspected of having breast cancer are usually referred for a breast biopsy to determine whether the lesion is cancerous. In most cases, breast lesions are not cancers and do not require further treatment...
Wednesday, November 25th, 2009
Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer. This protein, alpha-fetoprotein (AFP), may serve as a viable, well-tolerated agent for the treatment and prevention of breast cancer, according to findings published in Cancer Prevention Research, a journal of the American Association for Cancer Research...
Tuesday, November 24th, 2009
Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Pain Society...
Monday, November 23rd, 2009
Six outstanding contributors to the health and medical research industry were recognised by Research Australia in its annual "Thank You" Day awards. "The awards celebrate the achievements of individuals and organisations that have helped further research in Australia through corporate giving, philanthropy, advocacy or their own research contributions," said Rebecca James, Chief Executive Officer, Research Australia.
Friday, November 13th, 2009
Nearly half of all breast cancer patients experienced chronic pain two to three years after treatment and more than half felt discomfort, according to a study by Danish researchers published Tuesday in the Journal of the American Medical Association, the New York Times reports.
Wednesday, November 4th, 2009
Research at the Walter and Eliza Hall Institute into the genes involved in breast cancer development, new drugs for chronic pain, and the proteins involved in inflammatory diseases has received funding in this year's round of Australian Research Council (ARC) Discovery Project grants. Seven projects proposed by institute researchers have received ARC support.
Friday, October 23rd, 2009
Peter Criss, the 63-year old ex drummer and founding member of rock band KISS is talking to various media outlets this month, National Breast Cancer Awareness month, about how he was diagnosed and successfully treated for breast cancer last year. He wants men to be aware that it is not an exclusively female disease and if they spot a lump they should not be ashamed to get it checked straight away.
Thursday, October 15th, 2009
A genetic mutation implicated in breast and ovarian cancers could also have a role in causing heart failure, according to a new study reported at the 95th annual Clinical Congress of the American College of Surgeons. The researchers, led by Subodh Verma, MD, PhD, FRCSC, FAHA, report that mutation of the BRCA1 gene, long linked to breast cancers, also disrupts the normal replacement cycle of heart muscle cells in laboratory mice.
Tuesday, September 29th, 2009
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and help women at risk of these symptoms sooner in order to increase their chances of sticking with their treatment regimen.
Thursday, September 17th, 2009
1. Three Medications Reduce the Risk for Invasive Breast Cancer but Carry Heavy Risks for Adverse Events Breast cancer is the second most common cancer among women, causing 40,000 deaths a year. For women with a close family history of the disease, physicians may prescribe drugs to help reduce their risk of getting breast cancer. However, these medications carry their own potential health risks.
Tuesday, September 15th, 2009
In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone, apparently by targeting cancer stem cells, report Harvard Medical School researchers in the Sept. 14 advance online Cancer Research. "We have found a compound selective for cancer stem cells," said senior author Kevin Struhl, the David Wesley Gaiser professor of biological chemistry and molecular pharmacology at HMS.
Thursday, August 6th, 2009
The addition of the anaesthetic lidocaine to radiocolloid injection for sentinel- lymph-node (SLN) mapping in patients with early breast cancer reduces injection pain and improves patient comfort without compromising SLN identification, and should be introduced as standard practice, concludes an Article published Online First and in the September edition of The Lancet Oncology.